Find uplifting stories about heroes, innovations, and solutions
283 results for "** tourette syndrome"
Media entrepreneur Chude Jideonwo is breaking silence about living with Tourette syndrome after his doctor warned him not to speak publicly about it. His courage is helping change how neurological conditions are viewed across Africa.
A pharmaceutical company has submitted a groundbreaking treatment for Tourette syndrome that could become the first FDA-approved therapy specifically designed for the condition in over a decade. Thousands of families who've waited years for better options may soon have new hope.
Perth high school teacher Sharn Davidson makes dinosaur noises because of Tourette syndrome, and she's turned her tics into a powerful teaching tool about embracing differences. Her students named her two distinct roars "Kevin" and "Terry," and now she's helping other kids with the condition feel less alone.
British actor Robert Aramayo won Best Leading Actor at the BAFTAs for portraying John Davidson, a Scottish advocate who's changing how the world understands Tourette syndrome. The film "I Swear" celebrates Davidson's journey from isolation to becoming honored by Queen Elizabeth II.
A breakthrough medication could become the first FDA-approved treatment designed specifically for children with Tourette syndrome, reducing tics by 50% without the harsh side effects of current drugs. After a successful Phase III trial across 77 sites, the drug ecopipam is heading for FDA review.
Nigerian media entrepreneur Chude Jideonwo reveals his decades-long journey to a Tourette's Syndrome diagnosis in his bestselling memoir "How Depression Saved My Life." After years of doctors dismissing his symptoms, a neurologist finally gave him answers that transformed his relationship with his own mind.
Researchers at Harvard Medical School have developed a breakthrough gene-editing method that successfully silences the extra chromosome causing Down syndrome in up to 40% of lab cells. While still early stage, this proof-of-concept study opens the door to the first genuine treatment for one of the most common genetic conditions.
Breezy White just became the first person with Down syndrome to graduate from Georgia Highlands College and earn a college degree in Georgia. Her journey from childhood dream to 4.0 GPA student shows what's possible when opportunity meets determination.
A century after his birth, scientist Jérôme Lejeune's breakthrough discovery of Down syndrome's cause now powers a global network helping over 13,000 patients. The foundation bearing his name has become one of the world's leading research centers for genetic intellectual disabilities.
A middle schooler designed a onesie for infants with Down syndrome after watching her brother struggle with regular clothes. Her invention won top prize at Coweta County's Innovation Expo, where 60+ student teams pitched products to solve real problems.
Families affected by Hunter syndrome now have hope as the FDA approves Avlayah, the first treatment designed to replace a missing enzyme that causes dangerous sugar buildup in the brain. This breakthrough marks a major victory for patients with this rare genetic disease.
Researchers discovered that different mutations in Rett syndrome require different treatments, opening the door to personalized medicine for children with this developmental disorder. Using advanced brain tissue models, they successfully tested mutation-specific therapies that could help thousands of patients.
The FDA just approved Denali Therapeutics' new medicine for Hunter syndrome, bringing fresh hope to families affected by this rare genetic disease. The approval comes as a welcome surprise after the agency recently toughened its standards for rare disease treatments.
A groundbreaking treatment could help children with Dravet syndrome not just reduce seizures, but actually improve cognitive development and daily living skills. For the first time, families facing this devastating genetic condition have hope for a disease-modifying therapy.
Families dealing with Hunter syndrome just gained a powerful new treatment option after the FDA granted accelerated approval to Denali Therapeutics' groundbreaking drug. The decision marks a turning point for rare disease patients after a year of tougher regulatory outcomes.
Scientists at Texas Children's Hospital discovered a promising way to treat Rett syndrome, a rare disorder that affects 1 in 10,000 girls and currently has no cure. The breakthrough could help 65% of patients by boosting levels of a partially working protein in their brains.
Scientists at Texas Children's Hospital discovered a promising way to treat Rett syndrome, a rare disorder affecting 1 in 10,000 girls. The breakthrough could help 65% of patients by boosting levels of a partially working protein in their brains.
Scientists at MIT have discovered what causes leaky blood vessels in children with Rett syndrome and found a way to repair them. The breakthrough points toward potential treatments for a devastating disorder that affects thousands of young girls.
Scientists at MIT discovered why brain blood vessels become leaky in children with Rett syndrome and found a way to potentially fix it. The breakthrough traces the problem to a single overactive molecule that weakens blood vessel walls.
A new gene therapy has reduced seizures by up to 85% in children with Dravet syndrome, a devastating form of epilepsy that begins in infancy. Kids in the trial are not only having fewer seizures but are making friends and enjoying life alongside their peers for the first time.
Showing 20 of 283